The global pandemic COVID-19 is a contagious disease and its mortality rates ranging from 1% to 5% are likely due to acute respiratory distress syndrome (ARDS), and cytokine storm. A significant proportion of patients who require intubation succumb to the disease, despite the availability of ventilators and the best treatment practices. Researchers worldwide are in search of anti-inflammatory medicines in the hope of finding a cure for COVID-19. Low-level laser therapy (LLLT) has strong, anti-inflammatory effects confirmed by meta-analyses, and it may be therapeutic to ARDS.
https://pbmfoundation.org/wp-content/uploads/2020/07/cjrt-2020-015-g001.jpg 598 780 PBM Foundation https://pbmfoundation.org/wp-content/uploads/2020/09/PBM-Foundation-Logo.png PBM Foundation2020-07-01 12:33:332021-12-01 13:23:40Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19